Stockscreener 앱 받기
3.13
0.97%
0.03
시간 외 거래:
3.13
전일 마감가:
$3.10
열려 있는:
$3.11
하루 거래량:
265.83K
Relative Volume:
0.83
시가총액:
$120.76M
수익:
-
순이익/손실:
$-42.05M
주가수익비율:
-1.1099
EPS:
-2.82
순현금흐름:
$-35.26M
1주 성능:
+2.29%
1개월 성능:
+3.30%
6개월 성능:
-29.02%
1년 성능:
+64.74%
1일 변동 폭
$3.10
$3.21
1주일 범위
$3.02
$3.21
52주 변동 폭
$1.595
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
명칭
Protara Therapeutics Inc
전화
646-844-0337
주소
345 PARK AVENUE SOUTH, NEW YORK, NY
TARA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
3.13 | 119.99M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-16 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-07-10 | 재개 | Guggenheim | Buy |
| 2021-06-04 | 개시 | H.C. Wainwright | Buy |
| 2021-02-17 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-07-29 | 개시 | Guggenheim | Buy |
모두보기
Protara Therapeutics Inc 주식(TARA)의 최신 뉴스
Tick level data insight on Protara Therapeutics Inc. volatilityFree Weekly Hot Picks With Buy Confidence - Newser
Backtesting results for Protara Therapeutics Inc. trading strategiesDaily Market Momentum and Pressure Analysis - Newser
Understanding Protara Therapeutics Inc.’s price movementFree High Accuracy Alerts for ROI Traders - Newser
Published on: 2025-08-10 02:01:28 - Newser
How Protara Therapeutics Inc. stock performs during market volatilityFree Pattern Alert With ROI Driven Strategy - Newser
Does Protara Therapeutics Inc. fit your quant trading modelFree Entry Alert With Low Drawdown Strategy - Newser
News impact scoring models applied to Protara Therapeutics Inc.Intraday Movement Recap and Chart Summary - Newser
Protara Therapeutics Inc. stock volume spike explainedPattern Breakout Tracker with Screener Tools - Newser
Applying big data sentiment scoring on Protara Therapeutics Inc.Growth Summary Based on Market Positioning - Newser
Combining price and volume data for Protara Therapeutics Inc.Neural Network Based Equity Prediction System - Newser
Using data filters to optimize entry into Protara Therapeutics Inc.Stock Performance Summary Over One Year - Newser
What earnings revisions data tells us about Protara Therapeutics Inc.Free Trade Setups With AI Powered Filters - Newser
How to build a custom watchlist for Protara Therapeutics Inc.Short-Term AI-Based Stock Price Forecast - Newser
Using RSI to spot recovery in Protara Therapeutics Inc.Free Market Surge Signal for Swing Traders - Newser
Why Protara Therapeutics Inc. stock attracts strong analyst attentionSmart Entry Signals for Active Traders - Newser
What analysts say about Protara Therapeutics Inc. stockCapitalize on momentum stocks before they peak - Jammu Links News
When is Protara Therapeutics Inc. stock expected to show significant growthTransform your portfolio with high-yield stocks - Jammu Links News
How does Protara Therapeutics Inc. compare to its industry peersOutstanding trading profits - Jammu Links News
Should I hold or sell Protara Therapeutics Inc. stock in 2025Capitalize on market momentum for big wins - Jammu Links News
What catalysts could drive Protara Therapeutics Inc. stock higher in 2025Free Consultation - Jammu Links News
What are Protara Therapeutics Inc. company’s key revenue driversMaximize portfolio growth with expert advice - Jammu Links News
What are analysts’ price targets for Protara Therapeutics Inc. in the next 12 monthsPhenomenal returns - Jammu Links News
What is Protara Therapeutics Inc. company’s growth strategyGet real-time alerts on top stocks - Jammu Links News
What institutional investors are buying Protara Therapeutics Inc. stockDouble or triple returns - Jammu Links News
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Protara Therapeutics Grants $45K Worth of Stock Options and RSUs to Strategic New Employees - Stock Titan
Key External Factors That Drive Protara Therapeutics Inc. Stock Price MovementsRisk Managed Watchlist with Breakout Picks - Newser
Intrinsic Value of Protara Therapeutics Inc. Stock: Is It Undervalued or OvervaluedDaily Market Momentum Summary and Strategy - Newser
Fibonacci Retracement Aligns with Support in Protara Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
Is Protara Therapeutics Inc. a growth stock or a value stockAchieve breakthrough results with expert guidance - jammulinksnews.com
What is the dividend policy of Protara Therapeutics Inc. stockExceptional earning trajectories - Jammu Links News
How strong is Protara Therapeutics Inc. company’s balance sheetAchieve consistent double-digit returns - jammulinksnews.com
Why is Protara Therapeutics Inc. stock attracting strong analyst attentionFree Investment Timing Strategies - Jammu Links News
What makes Protara Therapeutics Inc. stock price move sharplyRapid capital growth - Jammu Links News
Protara Therapeutics Inc (TARA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):